Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022)
Lucid Diagnostics (LUCD) posted Depreciation and Depletion of $24000.0 for Q1 2022, up 4216.55% on a QoQ basis from $556.0 in Q4 2021, and up 700.0% year-over-year from $3000.0 in Q1 2021.
Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022) Analysis & Trends
Lucid Diagnostics' Depreciation and Depletion history runs 2 years deep, the most recent figure standing at $24000.0 for Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 24,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | 556.00 |
| Dec 31, 2021 | 556.00 |
| Mar 31, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |